TCL Archive “Absurd” Budget Cuts Would Devastate Cancer Program, Slash NCI Funds By $125 Million December 6, 1974
TCL Archive Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends December 9, 1988
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008
TCL Archive Amgen Replaces “Bundling” Contract With Three Separate Contracts For Growth Factors. September 5, 2008
TCL Archive Craig Thompson Of Abramson Center Named President, CEO, Of Memorial Sloan-Kettering September 3, 2010
